Prospective study of plasma enterolactone and prostate cancer risk (Sweden)
✍ Scribed by Pär Stattin; Annika Bylund; Carine Biessy; Rudolf Kaaks; Göran Hallmans; Herman Adlercreutz
- Book ID
- 106382162
- Publisher
- Springer Netherlands
- Year
- 2004
- Tongue
- English
- Weight
- 100 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Prolactin, a pituitary peptide hormone with multiple effects, stimulates prostate growth in experimental models. In humans, prolactin receptors are present in the prostate and are particularly abundant in pre-cancerous lesions. This suggests that prolactin could also be involved in the development o
## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.
## Abstract The role of folate metabolism in cancer development is a topic of much current interest, with maintenance of adequate folate status tending to show a protective effect. Aberrant methylation, primarily hypermethylation of certain genes including tumor suppressors, has been implicated in